Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia - Wikidata - awgldk - TriplyDB

Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia

Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia

http://www.wikidata.org/entity/Q34424573

about

The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of α7*nAChR function Alpha7 nicotinic acetylcholine receptor is a target in pharmacology and toxicology Effect of Pharmacological Interventions on the Fronto-Cingulo-Parietal Cognitive Control Network in Psychiatric Disorders: A Transdiagnostic Systematic Review of fMRI Studies Brain Functional Effects of Psychopharmacological Treatments in Schizophrenia: A Network-based Functional Perspective Beyond Neurotransmitter Systems The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function The role of alpha-7 nicotinic receptors in food intake behaviors Nicotinic ACh receptors as therapeutic targets in CNS disorders Top-Down Network Effective Connectivity in Abstinent Substance Dependent Individuals Innovative solutions to novel drug development in mental health Targeting Functional Biomarkers in Schizophrenia with Neuroimaging.Neuronal effects of nicotine during auditory selective attention in schizophrenia Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia.Nicotinic mechanisms in the treatment of psychotic disorders: a focus on the α7 nicotinic receptor Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia Functional magnetic resonance imaging of intrinsic brain networks for translational drug discovery Neuroimaging biomarkers for early drug development in schizophrenia Functional brain imaging of nicotinic effects on higher cognitive processes.Cortical parvalbumin GABAergic deficits with α7 nicotinic acetylcholine receptor deletion: implications for schizophrenia.Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.Nicotine elicits prolonged calcium signaling along ventral hippocampal axons.15q11.2-13.3 chromatin analysis reveals epigenetic regulation of CHRNA7 with deficiencies in Rett and autism brain.Transcriptional repression of the α7 nicotinic acetylcholine receptor subunit gene (CHRNA7) by activating protein-2α (AP-2α).Aberrant functional connectivity of default-mode network in type 2 diabetes patients.Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction.Transient inactivation of the neonatal ventral hippocampus impairs attentional set-shifting behavior: reversal with an α7 nicotinic agonist.A randomized exploratory trial of an α-7 nicotinic receptor agonist (TC-5619) for cognitive enhancement in schizophrenia.Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantine The potential role of dopamine D₃ receptor neurotransmission in cognition.Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational Biomarker Multiple genes in the 15q13-q14 chromosomal region are associated with schizophrenia.Default mode network activity in male adolescents with conduct and substance use disorder.Cortical synaptic NMDA receptor deficits in α7 nicotinic acetylcholine receptor gene deletion models: implications for neuropsychiatric diseases.Nicotine induction of theta frequency oscillations in rodent medial septal diagonal band in vitro.α7 Nicotinic receptor modulators for cognitive deficits in schizophrenia and Alzheimer's disease.3-(2,4-dimethoxybenzylidene)-anabaseine: a promising candidate drug for Alzheimer's disease?The emerging spectrum of allelic variation in schizophrenia: current evidence and strategies for the identification and functional characterization of common and rare variants.The vagal innervation of the gut and immune homeostasis Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia.Nicotinic modulation of intrinsic brain networks in schizophrenia.

P2860

Q24308763-29E8E3B2-66D5-4009-9AFF-2D6EFD5084CE Q24627240-FED62D38-4638-4B62-9A8D-4A86E72AA1CE Q26744718-F080D1E6-7E7E-4D82-83DC-262155B18C3B Q26786247-A2CC95A4-8780-4B9E-A559-9D406E224449 Q26821785-D97CC0AD-23F4-4322-90F7-592E46D9CBFC Q26830298-26ACFBB0-A15E-4D67-B531-EFC15F45B6F2 Q28111941-532DDBD6-BBC3-41B5-9642-811E1DCA9037 Q28552907-B477A1C5-B570-44DE-A364-4C2E0A3ED034 Q28677399-086A1F84-6AA3-4289-AEAE-55BB25702CF8 Q30366697-E4D99927-9948-4BC5-95C8-19E0B5FF3B6F Q30366764-0E6CF5A7-3538-45B7-B9BE-FA7DE3D3D4B9 Q30428422-92C24D5E-545E-4D3E-B264-498ED45DBCB6 Q30453198-ECFCFCB5-80D8-40CA-9D3B-55AAEFD593C7 Q30459624-5A53986A-7AEA-41A9-8E1C-3C4DF0125CF3 Q30829551-01611FF4-1BB5-4A8A-8EDB-E6C81BEBEF89 Q33632516-71DD57E5-A7B4-4572-B9B5-26C51B83F38D Q33935792-FF61DD57-BAB6-4142-A308-8F0FA0FBD631 Q34060159-461726B2-850B-451D-ABCA-87D806234B1D Q34274859-3F50C174-6C12-441B-85C5-418F0629B451 Q34640811-143814BB-A2F2-4695-B485-63B33CEDC2D1 Q35070465-A36A38BA-F3B1-45C4-94C6-E420B6C827E7 Q35389369-1FA95F76-F85D-499B-8F4A-BEB3140CB270 Q35604900-B6101ACA-207A-4DEF-A3D4-5CEB4609269D Q36128029-8E148BDE-BA10-4883-9B1B-69D61485C951 Q36189837-2EB64EBE-ABD8-4BA3-A950-A38018AC1EDB Q36234254-E6795A8B-E07D-4291-A75E-167489197752 Q36775219-20BEB5C7-FD0C-4094-90A8-48BD3F48D1EE Q36778677-124EE2C6-A247-4375-A439-BCDA5B040BB1 Q37106827-3AF780FF-7CE6-41F3-AF86-F6955C2BB9B0 Q37258840-0D809D95-C992-41A9-A397-298A8454C5F8 Q37427373-52248B83-1258-42C0-BCA9-B800B6354B46 Q37493567-9FF0D0EE-80FE-4C81-B3C6-14100D9C4457 Q37561567-05ABA7A3-0A8B-49AD-A928-FBEDB98CE13A Q37729077-CEABFC47-6219-4DC2-BA69-205CADCBD74E Q37952020-2C104E2B-09A2-43B5-8F2F-8F7440835D8C Q37980865-58FB842B-2FF7-4783-B711-F4BE86382EDA Q38006632-705461BB-7B33-48D3-B38F-80C26FB38CC3 Q38047774-3716377D-95E2-4C84-8671-8F9FC8399920 Q38066550-5E3780E4-4FE8-40E9-BD87-64CA75C6FEE4 Q38116676-22AFFBB4-2D7B-45BA-8985-43BBDCDE19B2

P2860

Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia

http://www.wikidata.org/entity/Q34424573

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia

@ast

Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia

@en

Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia

@nl

type

label

Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia

@ast

Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia

@en

Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia

@nl

prefLabel

Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia

@ast

Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia

@en

Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia

@nl

P1433

Q34424573-447712CD-EFB3-4F1F-9C1D-6BC641963469

P1476

Q34424573-2E0C0360-0052-420B-A40C-5E1438E34FB1

P2093

Q34424573-01229C7A-3450-42FB-B804-85D2508E8F22

Q34424573-75BAAFC6-3AFB-47E5-9145-37165086CD63

Q34424573-7DE43016-3003-49AE-A1D8-DD248D56E076

Q34424573-92E574B1-BD7F-420F-8137-A39227174374

Q34424573-A285D8BF-813A-4506-92CC-5831ACCFE7FF

Q34424573-B6D79A08-24BB-4B79-977E-25A686FDD4D6

Q34424573-B9705AF8-43C7-4F6B-845B-4267A0CD7FE8

Q34424573-D799100D-7F10-4C05-A9CA-56EE006FDC7E

Q34424573-E9A1FC20-BDFA-4FF4-80F3-A9CCF6F24C31

P2860

Q34424573-084D9CE9-49B5-4589-9774-3FDBF640E9FC

Q34424573-198325B7-177E-4CDF-A79C-1A69DF0B50DF

Q34424573-1E1E91AA-E9BB-45E5-9B16-B68EF8EC04DC

Q34424573-232B8A77-C04F-4C66-982C-D6E40971619E

Q34424573-40A255DD-6219-49EF-BF6F-F5E73E56A6F7

Q34424573-44158465-749F-4A8C-96B2-C6A3E06121CC

Q34424573-45FDC02F-AE29-47FC-99C4-FF6011645FF7

Q34424573-494DD6B1-5378-4CCD-960E-49C1972F1ED2

Q34424573-4C02A9B3-A167-48F4-B55A-487D1A94BEA2

Q34424573-4E7865DF-37A5-49C9-A264-8A65B37BBEA2

P304

Q34424573-D1F244AC-5B85-4A95-9E12-02479D809B8F

P31

Q34424573-DF46819B-74B9-4DCD-ADC7-AC69773B6F33

P356

Q34424573-EBAE6AB4-AE0F-4C53-930C-729FAF26DB0F

P407

Q34424573-0BDBA5F3-8EFC-4E8E-BF9E-C538E8A84314

P433

Q34424573-3703972B-BE40-45B2-91EF-9AED1E64BF92

P478

Q34424573-018561FA-E0FE-4B9F-B43B-D7595B3B69B5

P50

Q34424573-8958A132-1310-45A5-9067-87082FEE11D6

Q34424573-C6FC36FD-37F9-490E-A65A-14E69D2AEDFF

P577

Q34424573-13947E21-EF97-402D-A1DA-B59420DE1D47

P5875

Q34424573-B30E1784-A60D-434A-8A6B-1FC8615722AB

P698

Q34424573-D86E920F-E793-4C93-AAD0-9FE9416A3265

P921

Q34424573-28846A9F-5CCE-45E3-B9E2-C3F35A4EBD1F

P932

Q34424573-54759B5C-CDA6-41CB-A6ED-12EA54F14CBD

P356

J.BIOPSYCH.2010.07.004

P1433

Biological Psychiatry

P1476

Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia

@en

P2093

Ferenc Soti

http://www.w3.org/2001/XMLSchema#string

Jason R Tregellas

http://www.w3.org/2001/XMLSchema#string

Jody Tanabe

http://www.w3.org/2001/XMLSchema#string

Laura F Martin

http://www.w3.org/2001/XMLSchema#string

Lynn Johnson

http://www.w3.org/2001/XMLSchema#string

Robert Freedman

http://www.w3.org/2001/XMLSchema#string

Sherry Leonard

http://www.w3.org/2001/XMLSchema#string

Shireen Shatti

http://www.w3.org/2001/XMLSchema#string

William R Kem

http://www.w3.org/2001/XMLSchema#string

P2860

Default-mode brain dysfunction in mental disorders: A systematic review

Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia

Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia

The brain's default network: anatomy, function, and relevance to disease

An information-maximization approach to blind separation and blind deconvolution

Prevalence of smoking among psychiatric outpatients

Dysregulation of working memory and default-mode networks in schizophrenia using independent component analysis, an fBIRN and MCIC study

A method for making group inferences from functional MRI data using independent component analysis.

Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICA.

Resting state and task-induced deactivation: A methodological comparison in patients with schizophrenia and healthy controls

P304

7-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOPSYCH.2010.07.004

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45799312

http://www.w3.org/2001/XMLSchema#string

P698

20728875

http://www.w3.org/2001/XMLSchema#string

P921

P932

3005969

http://www.w3.org/2001/XMLSchema#string